Literature DB >> 18479353

Risk of renal stone formation induced by long-term bed rest could be decreased by premedication with bisphosphonate and increased by resistive exercise.

Atsushi Okada1, Hiroshi Ohshima, Yasunori Itoh, Takahiro Yasui, Keiichi Tozawa, Kenjiro Kohri.   

Abstract

OBJECTIVES: To clarify the influence of long-term bed rest on renal stone formation and to analyze the mechanism of bed-rest-induced stone formation and prevention by bisphosphonate and bed-rest exercise.
METHODS: Twenty-five men aged 26-48 years and divided into control (CON: n = 9), exercise (EX: n = 9), and pamidronate (PMD: n = 7) groups, rested on a 6 degrees head-down tilt bed for 90 days. The exercise group carried out resistive exercise every 3 days. Pamidronate (60 mg) was intravenously given 2 weeks before the initiation of bed rest. Abdominal X-ray examination and urine biochemistry were carried out during 90 days of bed rest and 90 days of reloading.
RESULTS: Renal stone formation was observed in two (22.2%) and four (44.4%) subjects in the control and exercise groups, respectively. No stone was seen in the pamidronate group. In the exercise group, urinary oxalate and phosphate excretion were significantly higher than in the control group. In the pamidronate group, urinary calcium excretion and relative supersaturation of calcium oxalate and brushite were lower than in the control group throughout the bed-rest and recovery period.
CONCLUSION: Long-term bed-rest-induced renal stone formation was found to be induced by increased urinary calcium and subsequent crystal formation of calcium oxalate and calcium phosphate. Exercise during bed rest for the prevention of bone mineral loss and contracture might increase the risk of renal stone formation. Pamidronate is useful for the prevention of renal stone formation during and after bed rest.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18479353     DOI: 10.1111/j.1442-2042.2008.02067.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  12 in total

Review 1.  The kidney in space.

Authors:  Vassilios Liakopoulos; Konstantinos Leivaditis; Theodoros Eleftheriadis; Nicholas Dombros
Journal:  Int Urol Nephrol       Date:  2012-09-22       Impact factor: 2.370

2.  Bisphosphonates as a supplement to exercise to protect bone during long-duration spaceflight.

Authors:  A Leblanc; T Matsumoto; J Jones; J Shapiro; T Lang; L Shackelford; S M Smith; H Evans; E Spector; R Ploutz-Snyder; J Sibonga; J Keyak; T Nakamura; K Kohri; H Ohshima
Journal:  Osteoporos Int       Date:  2013-01-19       Impact factor: 4.507

Review 3.  Biomolecular mechanism of urinary stone formation involving osteopontin.

Authors:  Kenjiro Kohri; Takahiro Yasui; Atsushi Okada; Masahito Hirose; Shuzo Hamamoto; Yasuhiro Fujii; Kazuhiro Niimi; Kazumi Taguchi
Journal:  Urol Res       Date:  2012-11-06

4.  Low Bone Density and Bisphosphonate Use and the Risk of Kidney Stones.

Authors:  Megan Prochaska; Eric Taylor; Anand Vaidya; Gary Curhan
Journal:  Clin J Am Soc Nephrol       Date:  2017-06-02       Impact factor: 8.237

5.  Bisphosphonate Use May Reduce the Risk of Urolithiasis in Astronauts on Long-Term Spaceflights.

Authors:  Atsushi Okada; Toshio Matsumoto; Hiroshi Ohshima; Tatsuya Isomura; Tadashi Koga; Takahiro Yasui; Kenjiro Kohri; Adrian LeBlanc; Elisabeth Spector; Jeffrey Jones; Linda Shackelford; Jean Sibonga
Journal:  JBMR Plus       Date:  2021-09-22

6.  Numerical characterization of astronaut CaOx renal stone incidence rates to quantify in-flight and post-flight relative risk.

Authors:  Debra A Goodenow-Messman; Suleyman A Gokoglu; Mohammad Kassemi; Jerry G Myers
Journal:  NPJ Microgravity       Date:  2022-01-28       Impact factor: 4.970

Review 7.  Space flight calcium: implications for astronaut health, spacecraft operations, and Earth.

Authors:  Scott M Smith; Torin McCoy; Daniel Gazda; Jennifer L L Morgan; Martina Heer; Sara R Zwart
Journal:  Nutrients       Date:  2012-12-18       Impact factor: 5.717

8.  Sex-specific responses of bone metabolism and renal stone risk during bed rest.

Authors:  Jennifer L L Morgan; Martina Heer; Alan R Hargens; Brandon R Macias; Edgar K Hudson; Linda C Shackelford; Sara R Zwart; Scott M Smith
Journal:  Physiol Rep       Date:  2014-08-07

9.  Inhibitory actions by ibandronate sodium, a nitrogen-containing bisphosphonate, on calcium-activated potassium channels in Madin-Darby canine kidney cells.

Authors:  Sheng-Nan Wu; Hui-Zhen Chen; Yu-Hung Chou; Yan-Ming Huang; Yi-Ching Lo
Journal:  Toxicol Rep       Date:  2015-08-28

10.  Effect of bisphosphonates on the crystallization of stone-forming salts in synthetic urine.

Authors:  Larisa Kovacevic; Hong Lu; Natalija Kovacevic; Yegappan Lakshmanan
Journal:  Investig Clin Urol       Date:  2020-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.